TrademarkDir
Serial #97404115
LIVE

Serial Number

97404115

Owner

GLENMARK THERAPEUTICS INC., USA

Attorney

Maxim A. Voltchenko

First Use Date

Jul 6, 2022

Filing Date

May 10, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #97404115 Trademark

Serial Number: 97404115 • Registration: 7698026

Serial #97404115 is a trademark filed by GLENMARK THERAPEUTICS INC., USA on May 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GLENMARK THERAPEUTICS INC., USA (40 trademarks)

MAHWAH, NJ 07430

Entity Type: 03

Trademark Details

Filing Date

May 10, 2022

Registration Date

February 18, 2025

First Use Anywhere

July 6, 2022

First Use in Commerce

August 1, 2022

Published for Opposition

June 6, 2023

Goods & Services

House mark for pharmaceutical preparations and chemical preparations for pharmaceutical or medical purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 19, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 23, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 23, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 17, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 17, 2024 AITU
USE AMENDMENT FILED
Jul 15, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 15, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 15, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 15, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 24, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 24, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 24, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2023 CNSA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 17, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2022 NWOS
NEW APPLICATION ENTERED
May 13, 2022 NWAP

Related Trademarks

More from this Owner

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS INC., USA

GLENMARK THERAPEUTICS INC., USA

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS INC., USA

GLENMARK THERAPEUTICS INC., USA

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS